A triallelic Fcγ receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcγRIIIa

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2948-2955

  De Haas, Masja ^a   Koene, Harry R ^a   Kleijer, Marion ^a   De Vries, Esther ^b   Simsek, Suat ^a   Van Tol, Maarten J D ^b   Roos, Dirk ^a   Von Dem Borne, Albert E G Kr ^a,c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000565424     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Van de Winkel, J. G. J., and P. J. A. Capel. 1993. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 14:215.
2. Warmerdam, P. A. M., J. G. J. Van de Winkel, E. J. Gosselin, and P. J. A. Capel. 1990. Molecular basis for a polymorphism of human Fc receptor II (CD32). J. Exp. Med. 172.19.
3. Clark, M. R., S. G. Stuart, R. P. Kimberly, P A. Ory, and I M. Goldstein. 1991 A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes Eur. J. Immunol 21:1911.
4. Scanlon, B. J , E. Scigliano, V. H. Freedman, M. C. Miedel, Y-C. E. Pan, J. C. Unkeless, and J. P. Kochan. 1989. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylmositol-anchored forms. Proc. Natl. Acad. Sci USA 86.5079.
5. Ravetch, J V., and B. Perussia 1989. Alternative membrane forms of FcRIII (CD16) on human NK cells and neutrophils: cell type-specific expression of two genes which differ in single nucleotide substitutions. J. Exp. Med. 170:481.
6. Peltz, G A , H. O. Grundy, R. V. Lebo, H. Yssel, G S. Barsh, and K. W Moore 1989. Human FcRIII: cloning, expression and identification of the chromosomal locus of the two Fc receptors for IgG Proc. Natl. Acad. Sci. USA 86:1013.
7. Ory, P. A., M R. Clark, E. E. Kwoh, S. B. Clarkson, and I. M. Goldstein. 1989. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J. Clin Invest 84:1688.
8. Huizinga, T. W. J., M. Kleijer, P. A Tetteroo, D. Roos, and A. E. G. Kr von dem Borne 1990. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phosphoinositol-linked Fcγ receptor III (CD16). Blood 75.213.
9. Ory, P. A , I. M. Goldstein, E E. Kwoh, and S. B. Clarkson 1989. Characterization of polymorphic forms of Fc receptor III on human neutrophils. J. Clin Invest. 83:1676.
10. Edberg, J. C , P. B. Redecha, J. E. Salmon, and R P. Kimberly. 1989. Human FcRIII (CD16): isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells. J. Immunol. 143:1642.
11. Huizinga, T. W. J., M de Haas, M. Kleijer, J. H Nuijens, D. Roos, and A. E G. Kr. von dem Borne 1990. Soluble Fcγ receptor III in human plasma originates from release by neutrophils J. Clin. Invest. 86.416.
12. de Haas, M , M. Kleijer, R. M. Minchinton, D Roos, and A. E. G. Kr. von dem Borne 1994. Soluble FcRIIIa is present in plasma and is derived from natural killer cells J Immunol. 152:900.
13. Hibbs, M. L.. M. Tolvanen, and O Carpen. 1994. Membrane-proximal Ig-like domain of FcRIII (CD16) contains residues critical for ligand binding. J Immunol. 152 4466.
14. Salmon, J E., J. C. Edberg, and R. P. Kimberly. 1990. Fcγ receptor III on human neutrophils: allelic variants have functionally distinct capacities J. Clin. Invest 85 1287.
15. Salmon, J. E., J. C. Edberg, N. L. Brogle, and R. P. Kimberly 1992. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB: independent mechanisms for differences in human phagocyte function. J. Clin. Invest. 89: 1274.
16. Bredius, R. G. M , C. A. P Fijen, M. de Haas, E J. Kuijper, R. S. Weening, J. G. J. Van de Winkel, and T. A. Out. 1994. Role of neutrophil FcRH (CD32) and FcRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 83:624.
17. de Haas, M., M. Kleijer, D. Roos, and A. E. G. Kr. von dem Borne. 1994. Characterization of mAbs of the CD16 cluster and six newly generated CD16 mAbs. In Leukocyte Typing V: White Cell Differentiation Antigens. S. F. Schlossman, L Boumsell, W. Gilks, J. M Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. L. Silverstein, T. A. Springer, T. A Tedder, and R F. Todd, eds. Oxford University Press, Oxford, pp. 011-014.
18. Perussia, B., S. Starr, S. Abraham, V Fanning, and G. Trinchieri. 1983. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J. Immunol. 130:2133.
19. Kieijer, M., M. de Haas, D Roos, and A. E. G. Kr. von dem Borne. 1995. Penl, a novel FcRIII mAb with a unique specificity for neutrophil NA2-FcRIIIb carrying a small N-linked oligosaccharide moiety. In Leukocyte Typing V. S. Schlossman, ed Oxford University Press, Oxford, p. 78
20. Perussia, B , and J. V Ravetch. 1991. FcγRIII (CD16) on human macrophages is a functional product of the FcγRIII-2 gene Eur. J. Immunol. 21:425.
21. Huizinga, T. W. J , R. W Kuijpers, M. Kleijer, T. W. Schulpen, H. T Cuypers, D. Roos, and A. E. G. Kr. von dem Borne. 1990. Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood 76:1927.
22. De Haas, M , M. Kleijer, R. van Zwieten, D Roos, and A. E G. Kr. von dem Borne. 1995. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 donors from 14 families. Blood 86:2403.
23. Lanier, L L., J. H Phillips, and R Testi 1989. Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes Eur. J. Immunol. 19:775.
24. Roos, D.. and M. de Boer. 1986 Purification and cryopreservation of phagocytes from human blood. Meth. Enzymol. 132:225.
25. Fromont, P., A. Bettaieb, H. Skouri, C. Floch, E. Poulet, N. Duedari, and P. Bierling. 1992 Frequency of the polymorphonuclear Fcγ receptor III deficiency in the French population and us involvement in the development of neonatal alloimmune neutropenia. Blood 79:2131.
26. Trounstine, M. L , G. A. Peltz, H. Yssel, T. W. J. Huizinga, A. E. G. Kr. von dem Borne, H. Spits, and K. W Moore. 1990. Reactivity of cloned, expressed human FcRIII isoforms with monoclonal antibodies which distinguish cell type-specific and allelic forms of FcRIII. Int. Immunol. 2.303.
27. Vance, B. A., T. W. J. Huizinga, K. Wardwell, and P M. Guyre 1993. Binding of monomeric human IgG defines an expression polymorphism of FcRIII on large granular lymphocyte/natural killer cells. J. Immunol. 151:6429.
28. Huizinga, T. W. J., M Kerst, J H. Nuijens, A Vlug, A. E. G. Kr von dem Borne, D. Roos, and P. A T. Tetteroo 1989. Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J. Immunol. 142:2359.
29. Hulett, M. D., E. Witort, R. I. Brinkworth, I. F. C. McKenzie, and P. M. Hogarth 1994 Identification of the IgG binding site of the human low affinity receptor for IgG FcRII J. Biol. Chem. 269:15287.
30. Hulett, M. D., E. Witort, R. I Brinkworth, I. F. C McKenzie, and P. M. Hogarth. 1995. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J. Biol. Chem 270.21188.
31. Perussia, B., G. Trinchieri, A. Jackson, N. L. Warner, J. Faust, H. Rumpold, D. Kraft, and L L Lanier. 1984 The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J. Immunol. 133.180.
32. Osborne, J. M., G. W. Chacko, J. T. Brandt, and C. L. Anderson. 1994. Ethnic variation in frequency of an allelic polymorphism of human FcRIIA determined with allele-specific oligonucleotide probes J. Immunol. Methods 173:207.
33. Ohto, H., and Y. Matso. 1989 Neutrophil-specific antigens and gene frequencies in Japanese population. Transfusion 29:654.
34. Abo, T , A. B. Tilden, C M Balch, K. Kumagai, G M. Troup, and M. D. Cooper. 1984. Ethnic differences in the lymphocyte proliferative response induced by a munne IgG1 antibody, Leu-4, to the T3 molecule. J. Exp. Med. 160:303.
35. Qiao Qiu, W , D. De Bruin, B. H Brownstein, R. Pearse, and J. V. Ravetch 1990. Organization of the human and mouse low-affinity Fcγ receptor genes: duplication and recombination Science 248:732
36. Su, Y., D. G. Brooks, L. Lanying, J. Lepereq, J. A. Trofatter, J. V. Ravetch, and R V. Lebo. 1993. Myelin protein zero gene mutated in Charcot-Marie-Tooth type IB patients. Proc. Natl Acad. Sci. USA 90:10856
37. Ravetch, J. V. 1994. Fc receptors. Rubor redux. Cell 78-553.
38. Ortaldo, J. R , A. T. Mason, and J. J O'Shea. 1995 Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med 181.339.
39. Azzoni, L., I. Anegon, B. Calabretta, and B. Perussia. 1995. Ligand binding to FcγRIII induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154.491.
40. Clarkson, S. B , J. B. Bussel, R. P Kimberly, J. E. Valinsky, R. L. Nachman, and J. C Unkeless. 1986. Treatment of refractory immune thrombocytopenic purpura with an anti-Fey receptor antibody. N. Engl. J Med. 314:1236.
41. Soubrane, C., J M. Tourani, J. M. Andrieu, S. Visonneau, K. Beldjord, D. Israel-Biet, R. Mouawad, J. Bussel, M Weil, and D. Khayat. 1993. Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic prupura patient. Blood 81:15.